Jacobus Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Jacobus Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,760	Closed	-$274K	–	217
2016 Q3	$274K	Hold	4,760	–	–	0.08%	151
2016 Q2	$279K	Hold	4,760	–	–	0.09%	144
2016 Q1	$274K	Hold	4,760	–	–	0.08%	178
2015 Q4	$311K	Hold	4,760	–	–	0.09%	159
2015 Q3	$300K	Hold	4,760	–	–	0.09%	165
2015 Q2	$337K	Hold	4,760	–	–	0.08%	167
2015 Q1	$334K	Hold	4,760	–	–	0.09%	162
2014 Q4	$306K	Hold	4,760	–	–	0.08%	168
2014 Q3	$303K	Hold	4,760	–	–	0.08%	173
2014 Q2	$295K	Sell	4,760 -800	-14%	-$47.5K	0.08%	183
2014 Q1	$325K	Hold	5,560	–	–	0.08%	182
2013 Q4	$295K	Hold	5,560	–	–	0.09%	174
2013 Q3	$266K	Hold	5,560	–	–	0.09%	152
2013 Q2	$253K	Buy	+5,560	New	+$257K	0.09%	149

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Colrain Capital Boston, Massachusetts $259M AUM 63.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return

Jacobus Wealth Management's PPH Position: Q4 2016 in Review

Jacobus Wealth Management sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2016, closing a stake of 4,760 shares — an estimated $274K sold.

Jacobus Wealth Management first reported a position in PPH in Q2 2013 and held it in 14 quarters. The position peaked at $337K in Q2 2015. 51 funds tracked by Wall St. Rank hold PPH as of Q4 2016.

Jacobus Wealth Management reported no remaining VanEck Pharmaceutical ETF position as of Q4 2016 after selling out during the quarter.
Jacobus Wealth Management sold 4,760 VanEck Pharmaceutical ETF shares in Q4 2016, an estimated $274K.
Jacobus Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 14 quarters.
Jacobus Wealth Management's VanEck Pharmaceutical ETF position peaked at $337K in Q2 2015.
51 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2016.

Based on Jacobus Wealth Management's 13F filing for Q4 2016, filed 3 Feb 2017.